Curr cancer drug targets impact factor
WebImpact Factor: 4.850 5-Year Impact Factor: 3.111 Subscribe ISSN: 2212-392X (Online) ISSN: 1574-8936 (Print) Download PDF Flyer. Abstracted & Indexed in: ... Current Cancer Drug Targets. Impact Factor: 2.907 5-Year Impact Factor: 3.516 Subscribe ISSN: 1873-5576 (Online) ISSN: 1568-0096 (Print) WebMay 27, 2024 · The impact score (IS) 2024 of Current Cancer Drug Targets is 2.76, which is computed in 2024 as per its definition.Current Cancer Drug Targets IS is decreased …
Curr cancer drug targets impact factor
Did you know?
WebIt is a companion to the highly regarded review journal Current Opinion in Pharmacology (2024 Journal Impact Factor 5.547, CiteScore 9.3) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a ... WebApr 7, 2024 · Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs. Papers are not restricted to drugs delivered ...
WebIn this study, we investigate whether miR-34a plays a critical role in the control of cell growth and apoptosis in PC cells. We found that Re-expression (forced expression) of miR-34a inhibits ... WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current Cancer Drug Targets. ISSN (Print): 1568-0096 ... Volume 23, Issue 2, 2024 Review Article Characteristic Hallmarks of Aging and the Impact on Carcinogenesis. Pp: 87-102 Author ...
WebCurrent Cancer Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has an SJR impact factor of 0.732 and it has a best quartile of Q2. It is published in English. It has an SJR … WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096 ISSN (Online): 1873-5576 Volume 23 , Issues 11, 2024. This journal supports open access. Back Journal Home Submit …
WebColorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related deaths in the world with an estimated number of 1.8 million new cases and about 881,000 deaths worldwide in 2024. The epidemiology of CRC varies significantly between different regions in the world … mimic sweaterWebAge itself is a risk factor for the onset of most cancers while evidence suggests that cancer and its treatments might accelerate aging by causing genotoxic and cytotoxic insults. … Characteristic Hallmarks of Aging and the Impact on Carcinogenesis Curr Cancer Drug Targets. 2024 Aug 16. doi: 10.2174 ... mimic streaming itaWebCurr Cancer Drug Targets. 2015;15(8):739-49. doi: 10.2174/156800961508151001105814. ... These results suggest that the expression of CDK8 and its interactive genes has a profound impact on the response to adjuvant therapy in breast cancer in accordance with the role of CDK8 in chemotherapy-induced tumor … mimics 中文培训手册Web13 rows · About Current Cancer Drug Targets. Current Cancer Drug Targets aims to cover all the latest and ... mimics vrWebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner Search anything here mimics 意味WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current … mimic statue seed terrariaWebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner. ... Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles ... mimic stukent personal finance